Back to results
CompletedPhase 4

Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan

NCT02694263

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University Hospitals of Leicester NHS Trust

Leicester, Leicestershire, United Kingdom

+1 additional location

View on ClinicalTrials.gov
Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan — TrialFind